MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000550807

Медицинская библиотека · Kidney diseases (Basel, Switzerland) · 2026

Long-Term Outcomes in Patients with Renal Systemic Light Chain Amyloidosis.

Ye Yujie, Guo Jinzhou, Chen Wencui, Wu Xiaomei, Xu Weiwei, Huang Xianghua

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Metabolic syndrome (MetS) is common in aging men, but the age-specific relationship between the testosterone-to-estradiol (T/E2) ratio and metabolic abnormalities remains insufficiently characterized. This study evaluated age-stratified associations between the T/E2 ratio and MetS-related parameters in middle-aged and elderly Chinese men.

METHODS

This retrospective cross-sectional study included 120 Chinese men aged 46-75 years. Participants were divided into three age groups: 46-55, 56-65, and 66-75 years. Serum testosterone, estradiol, sex hormone-binding globulin (SHBG), anthropometric indices, blood pressure, fasting blood glucose, and lipid profiles were assessed. MetS components were defined according to IDF-based criteria, and TyG index and TyG-BMI were calculated. Age-stratified Pearson correlation analyses were performed, with Spearman correlation and FDR adjustment used for sensitivity analyses.

RESULTS

The T/E2 ratio decreased significantly across age groups, while SHBG increased and T/SHBG decreased with age. In the 46-55-year group, the T/E2 ratio was inversely correlated with fasting blood glucose, waist circumference, TyG-BMI, and total MetS points score. In the 66-75-year group, the main inverse association was observed between the T/E2 ratio and triglycerides. No consistent significant associations were observed in the 56-65-year group. Sensitivity analyses showed generally consistent directions for the main associations.

CONCLUSIONS

The T/E2 ratio shows age-related decline and age-specific associations with selected MetS-related parameters in middle-aged and elderly Chinese men. These findings suggest that the T/E2 ratio may reflect age-related metabolic heterogeneity, but prospective studies are needed to clarify its longitudinal and clinical relevance.

Для цитирования: Ye Yujie, Guo Jinzhou, Chen Wencui, Wu Xiaomei, Xu Weiwei, Huang Xianghua. Long-Term Outcomes in Patients with Renal Systemic Light Chain Amyloidosis.. Kidney diseases (Basel, Switzerland). 2026. DOI: 10.1159/000550807.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.